✨ Free AI Report
HeartFlow, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research HeartFlow, Inc.
Company Research

HeartFlow, Inc.: Business Overview, Financials & Competitive Analysis

HeartFlow, Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). Market-leading position in AI-driven coronary artery disease diagnosis with strong growth but facing reimbursement headwinds and a race to profitability. Strong revenue growth momentum (44% increase in 2024 to $125.8M, 39% YoY in Q1 2025) and recent IPO capital position strengthen the company, but accumulated $1.1 billion deficit and $43.4.

HeartFlow is a medical technology company providing non-invasive solutions for diagnosing and managing coronary artery disease worldwide through its AI-powered platform that uses computational fluid dynamics to create...

6/ 10Solid

Cyborg Score thesis

Market-leading position in AI-driven coronary artery disease diagnosis with strong growth but facing reimbursement headwinds and...

Read the full analyst-debate transcript →
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest HeartFlow, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for HeartFlow, Inc.

AskCyborg analysts argue the bull and bear cases for HeartFlow, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
HeartFlow, Inc. OverviewStrategic ProfileCompetitive Landscape
Get Interactive Report Freeor start reading below

HeartFlow, Inc. Overview

Pro stress-test →

HeartFlow is a medical technology company providing non-invasive solutions for diagnosing and managing coronary artery disease worldwide through its AI-powered platform that uses computational fluid dynamics to create personalized 3D cardiac models and provide insights on blood flow, stenosis, and plaque composition. The platform has been used to assess CAD in over 400,000 patients, establishing market leadership in AI-driven cardiac imaging.

Strategic Profile

Pro stress-test →

HeartFlow's cloud-based, hardware-agnostic platform allows any hospital with a CT scanner to upload images and receive analysis within hours, eliminating upfront capital expenditure and reducing marginal cost per diagnosis. The company is at a reimbursement inflection point with major payer coverage expansions for its Plaque Analysis product, though CMS's proposed 2026 reimbursement cut threatens core FFR CT Analysis revenue.

Competitive Landscape

Pro stress-test →

Major equipment manufacturers (GE Healthcare, Siemens Healthineers, Philips, Canon Medical) represent competitive threats through hardware-centric models requiring capital investment, and all have considered or developed competing CT-based blood flow analysis tools. Competitors like Cleerly with FDA-cleared coronary CT analysis and partnerships between Philips and Myocardial Solutions offer alternative approaches to cardiac imaging.

What the analysts stress-tested

The top findings that survived the multi-agent debate for HeartFlow, Inc..

  • Near-monopoly status in AI-driven non-invasive CAD diagnosis with 98% revenue concentration in core FFR CT Analysis product
  • Major payer expansions including Aetna coverage for Plaque Analysis effective December 2025 following similar moves by Cigna and UnitedHealthcare
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026GAMEFILM Registry expanded to include NBA and NHL players, building on initial NFL alumni phase
  • Dec 2025Aetna coverage expansion for Heartflow Plaque Analysis across Commercial, Medicare Advantage, and Medicaid plans
  • +2 moreTrack every material event for HeartFlow, Inc. as it happens. Explore monitoring →
Get alerted when HeartFlow, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CT-based FFR Analysis ToolsTraditional imaging equipment manufacturers developing competitive blood flow analysis bundled with hardware→CleerlyFDA-cleared coronary CT analysis software using mobile scanners for underserved communities→Myocardial SolutionsCardiac MRI enhancement for cancer patients at risk of heart damage from treatment→

Compare HeartFlow, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account
NEW · MCP server

Ask your AI assistant about HeartFlow, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare HeartFlow, Inc. and its top competitor on Cyborg Score”
“What did HeartFlow, Inc. do this quarter?”
“Is HeartFlow, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does HeartFlow, Inc. do?+
HeartFlow is a medical technology company providing non-invasive solutions for diagnosing and managing coronary artery disease worldwide through its AI-powered platform that uses computational fluid dynamics to create...
What is HeartFlow, Inc.'s Cyborg Score?+
HeartFlow, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are HeartFlow, Inc.'s main competitors?+
Named competitors include CT-based FFR Analysis Tools, Cleerly, Myocardial Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full HeartFlow, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the HeartFlow, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track HeartFlow, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.